Groups | Robotic-therapy group | Control group | Intergroup p-value | Bonferroni correction | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Outcomes | Pre-Therapy | Post-Therapy | Difference of mean | Robotic group p-value | Pre-therapy | Post-therapy | Difference of mean | Control group p-value | ||
Mean + Std dev | Mean + Std dev | |||||||||
Clinical scales | ||||||||||
MAS | 1.75 ± 0.2 | 1.29 ± 0.3 | 0.46 | 0.0009 | 1.86 ± 0.5 | 1.59 ± 0.6 | 0.27 | 0.12 | 0.03* | 0.19 |
AROM | 15.00 ± 9.7 | 34.50 ± 14.50 | 19.580 | 0.0004 | 13.60 ± 7.70 | 20.00 ± 8.00 | 6.4 | 0.002 | 0.02* | 0.07 |
BI | 74.1 ± 12.4 | 89.1 ± 7.9 | 15 | 0.0009 | 69.5 ± 12.9 | 82.7 ± 14.3 | 13.18 | 0.0009 | 0.82 | 0.48 |
BS | 3.6 ± 0.7 | 4.8 ± 0.9 | 1.16 | 0.0004 | 3.72 ± 1 | 4.4 ± 1.2 | 0.73 | 0.015 | 0.311 | 0.27 |
FMU/L | 36 ± 7.7 | 50.2 ± 6.5 | 14.2 | 0.0004 | 37.4 ± 9.1 | 45.4 ± 9.7 | 8 | 0.0009 | 0.039* | 0.04# |
FMW/H | 9.7 ± 2.7 | 16.6 ± 4.3 | 6.9 | 0.0004 | 11.4 ± 2.9 | 15.1 ± 3.6 | 3.73 | 0.0009 | 0.012* | 0.01# |
FMS/E | 26.2 ± 5.6 | 33.5 ± 3.8 | 7.3 | 0.0009 | 26 ± 7.07 | 29.8 ± 7.08 | 3.8 | 0.002 | 0.13 | 0.28 |
∆FM W/H | 0.73 ± 0.45 | 0.33 ± 0.14 | 0.012* | 0.01# | ||||||
Cortical-excitability | ||||||||||
RMT IL | 95.3 ± 7.8 | 79.58 ± 14.38 | 15.17 | 0.0039 | 89 ± 16.03 | 85.18 ± 17.9 | 3.82 | 0.12 | 0.027* | 0.02# |
MEP A IL | 39.4 ± 60.4 | 94.3 ± 63.2 | 54.9 | 0.048 | 38.1 ± 55.9 | 38.24 ± 40 | 0.14 | 0.312 | 0.014* | 0.04# |
RMT CL | 67.33 ± 10.1 | 65.08 ± 11.12 | 2.25 | 0.051 | 68.09 ± 11.7 | 66.18 ± 12.57 | 1.91 | 0.052 | 0.87 | 0.65 |
MEP A CL | 506.33 ± 247 | 355.3 ± 191.5 | 151.03 | 0.23 | 200.2 ± 77 | 185.4 ± 268.3 | 14.8 | 0.41 | 0.65 | 0.37 |
RMTasym | 1.43 ± 0.21 | 1.25 ± 0.31 | 0.18 | 0.012 | 1.33 ± 0.32 | 1.30 ± 0.28 | 0.03 | 0.59 | 0.028* | 0.035# |
∆RMTipsi | 0.16 ± 0.12 | 0.04 ± 0.09 | 0.023* | 0.017# | ||||||
∆RMT asym ratio | 0.12 ± 0.14 | 0.011 ± 0.1 | 0.028* | 0.034# |